At Huntsville Main/W&C/Madison, orders for this medication should be rejected and reviewed by an oncology clinical specialist or an oncology pool member (see second page of the document "Hormone Therapies and Guidance on Oral Chemotherapy") 

Revlimid medication guide

Thalidomide derivative indicated for the treatment of transfusion-dependent anemia in patients with specific types of myelodysplastic syndrome. It is only available through a special registry program called Rev-Assist, where the drug is directly sent to the patient. The hospital may not obtain the drug, patients would have to use their own supply.

Reviewed: February 28, 2006

REMS (Revlimid): View FDA REMS Info

• Micromedex
• UpToDate
• Lippincott Advisor